MoonLake Immunotherapeutics (MLTX) Other Working Capital Changes (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) recorded quarterly Other Working Capital Changes of -$389000.0 in Q1 2026, down 3.18% quarter-over-quarter from -$377000.0 in Q4 2025, and down 42.49% on a YoY basis from -$676414.0 in Q1 2025.
MoonLake Immunotherapeutics (MLTX) Other Working Capital Changes (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at -$389000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 42.49% year-over-year to -$389000.0; the TTM figure through Mar 2026 stood at -$1.3 million (down 111.35% YoY), while the FY2025 annual figure was -$1.2 million, down 109.48% from the prior year.
- Other Working Capital Changes was -$389000.0 for Q1 2026 at MoonLake Immunotherapeutics, down from -$377000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $8.2 million in Q3 2024 to a low of -$3.2 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged $641622.1 across 5 years, with a median of -$171000.0 in 2025.
- Biggest YoY gain for Other Working Capital Changes was 12808.36% in 2022; the steepest drop was 37766.59% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$3.2 million in 2022, then soared by 96.73% to -$104168.0 in 2023, then jumped by 5255.13% to $5.4 million in 2024, then tumbled by 107.02% to -$377000.0 in 2025, then retreated by 3.18% to -$389000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$389000.0 (Q1 2026), -$377000.0 (Q4 2025), and -$401000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | MoonLake Immunotherapeutics | 1.25 Bn | 888.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -389,000.00 |
| Mar 31, 2026 | -389,000.00 |
| Dec 31, 2025 | -377,000.00 |
| Dec 31, 2025 | -377,000.00 |
| Sep 30, 2025 | -401,000.00 |
| Sep 30, 2025 | -401,000.00 |
| Jun 30, 2025 | -171,000.00 |
| Jun 30, 2025 | -171,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Mar 31, 2025 | -273,000.00 |
| Dec 31, 2024 | 5.37 Mn |
| Dec 31, 2024 | 5.37 Mn |
| Sep 30, 2024 | 8.25 Mn |
| Sep 30, 2024 | 8.25 Mn |
| Jun 30, 2024 | -1.56 Mn |
| Jun 30, 2024 | -1.56 Mn |
| Mar 31, 2024 | 833,000.00 |
| Mar 31, 2024 | 833,000.00 |
| Dec 31, 2023 | -104,168.00 |
| Dec 31, 2023 | -104,168.00 |